Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Revenue

26 Followers

Shanghai Fosun Pharmaceutical (Group) Co Revenue

Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 20.10B in the quarter ending Jun 30, 2026, with 99.49%. This bring the company's revenue in the last twelve months to 61.75B, Decreased 19.33%. In the fiscal year ending Dec 31, 2025, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 40.42B with -1.57% growth.

Revenue (ttm)

61.75B

Revenue Growth

9.50%

P/S Ratio

0.20

Revenue/Employee

$995,599

Employees

40,603

Market Cap

$8.18B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	40.42B	-642.89M	-1.57%
Dec 31, 2024	41.07B	-332.34M	-0.80%
Dec 31, 2023	41.40B	-2.55B	-5.81%
Dec 31, 2022	43.95B	4.95B	+12.68%
Dec 31, 2021	39.01B	8.70B	+28.70%
Dec 31, 2020	30.31B	1.72B	+6.02%
Dec 31, 2019	28.59B	3.67B	+14.72%
Dec 31, 2018	24.92B	6.38B	+34.45%
Dec 31, 2017	18.53B	―	―